What is Humalog insulin lispro used for?
Humalog mealtime insulins are used to treat people with type 1 or type 2 diabetes for the control of high blood sugar. Humalog is a fast-acting insulin that starts working faster and works for a shorter period of time than regular human insulin.
Can Humalog cause kidney problems?
You’re more likely to have low blood sugar levels while taking Humalog if you have liver or kidney problems. Examples of these problems include kidney failure and liver failure. Your doctor can discuss ways to help prevent low blood sugar levels while taking Humalog.
What is the indication for insulin lispro?
Insulin lispro is an insulin analog that is FDA-approved for the treatment of patients with diabetes mellitus types 1 and 2 to control hyperglycemia.
Who should not take Humalog?
You should not use Humalog if you are allergic to insulin, or if you are having an episode of hypoglycemia (low blood sugar). Humalog should not be given to a child younger than 3 years old. Humalog should not be used to treat type 2 diabetes in a child of any age.
What is the alternative to Humalog?
There are other insulin options to Humalog. While the cash prices of these alternatives may not be significantly less expensive, depending on your insurance coverage, some might be more affordable. Lantus (insulin glargine), and its biosimilar Basaglar , which we mentioned above, have been found to be just as safe and effective as Humalog.
Can Humalog cause stomach pain?
Abdominal pain is found among people who take Humalog, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Lantus, and have High blood pressure.
What is the adverse effect of insulin?
Common side effects may include: low blood sugar; itching, mild skin rash; or thickening or hollowing of the skin where you injected the medicine.
Can Toujeo cause hyperglycemia?
Serious side effects that can occur in people using Toujeo or Tresiba may include: Although both Toujeo and Tresiba can cause hypoglycemia, Toujeo may have a lower risk of this condition. In one study, Toujeo had a lower risk of hypoglycemia than Tresiba when these medications were first started and dosages were being increased.
